A Hospital-Based Registry of Preventive Cardiology Clinics
NCT ID: NCT06503341
Last Updated: 2024-07-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2021-06-17
2041-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Outcomes of Cardiovascular Disease
NCT06459934
Clinical Characteristics and Outcomes of Coronary Heart Disease
NCT06335901
Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
NCT04684264
Screening and Secondary Prevention Rheumatic Heart Disease Study
NCT05991219
Cardiovascular Disease Prevention Strategies for High-risk Urban Sedentary Employees in Karachi, Pakistan
NCT06981247
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sampling Technique: Non-probability consecutive sampling Data Collection Procedure: Verbal informed consent will be obtained from all the patients regarding their participation in the study and publication of study findings while maintaining confidentiality. Consecutive patients presenting preventive cardiology clinics at the National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan, will be included in this registry. Demographic characteristics, physical examination, clinical history, risk modification, lab assessment, and ASCVD risk score at presentation and at every follow-up will be recorded using a structural questionnaire.
Data Analysis Procedure: The Tentative analysis plan uses collected data for research publications. The statistical package for social sciences (SPSS 21) will be used to analyze baseline characteristics. The Shapiro-Wilk test will be applied to check the hypothesis of normality for quantitative (continuous) variables. Descriptive statistics such as mean ± SD, median (IQR), skewness, maximum, and minimum will be calculated for quantitative (continuous) variables. Frequency and percentages will be calculated for categorical variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adult patients
Adult patients with or without cardiovascular diseases.
Cardiovascular risk assesment
ASCVD Score and WHO Cardiovascular Risk score.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cardiovascular risk assesment
ASCVD Score and WHO Cardiovascular Risk score.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Cardiovascular Diseases, Pakistan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr Rubina Rauf
Assistant Professor Preventive Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Dr Rubina Rauf
Role: PRINCIPAL_INVESTIGATOR
National Institute of Cardiovascular Diseases
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Cardiovascular Diseases
Karachi, Sindh, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Rauf R, Khan MN, Sial JA, Qamar N, Saghir T, Kazmi KA. Primary prevention of cardiovascular diseases among women in a South Asian population: a descriptive study of modifiable risk factors. BMJ Open. 2024 Nov 14;14(11):e089149. doi: 10.1136/bmjopen-2024-089149.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-20/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.